Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell transplantation in multiple sclerosis: multiple choices and multiple challenges.

R Q Hintzen1

  • 1Department of Neurology, Erasmus Medical Centre Rotterdam, The Netherlands. rhintzen@xs4all.nl

Multiple Sclerosis (Houndmills, Basingstoke, England)
|May 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of MOG antibody associated disorders: results of an international survey.

Journal of neurology·2020
Same author

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults.

Multiple sclerosis (Houndmills, Basingstoke, England)·2019
Same author

Response to Vilariño-Güell et al.

Multiple sclerosis (Houndmills, Basingstoke, England)·2018
Same author

Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.

Journal of neurology·2018
Same author

Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.

European journal of neurology·2018
Same author

No excess of autoimmune diseases in multiple sclerosis families from the Netherlands.

Acta neurologica Scandinavica·2018

Hematopoietic stem cell transplantation (HSCT) is a feasible approach for multiple sclerosis (MS). However, current data is insufficient to draw firm conclusions on its efficacy due to short follow-up periods and small patient groups.

Area of Science:

  • Neuroimmunology
  • Hematology
  • Transplantation Medicine

Background:

  • Multiple sclerosis (MS) is an autoimmune central nervous system disorder.
  • The concept of MS as an autoimmune disease suggests immunosuppression and stem cell transplantation may halt disease progression.
  • Positive results in animal models and anecdotal human reports have spurred HSCT programs for MS.

Purpose of the Study:

  • To evaluate the feasibility and safety of hematopoietic stem cell transplantation (HSCT) for multiple sclerosis (MS).
  • To address the need for systematic analysis of different HSCT methodologies in MS treatment.

Main Methods:

  • Initiation of HSCT programs worldwide for MS patients.
  • Preliminary data collection and analysis from ongoing studies.

Related Experiment Videos

Main Results:

  • HSCT is technically feasible in MS patients.
  • The safety profile of HSCT in MS appears comparable to that in hemato-oncological diseases.
  • Current data is limited by short follow-up periods, small patient cohorts, and heterogeneity in patient selection and protocols.

Conclusions:

  • Overenthusiastic expectations for HSCT in MS should be tempered due to preliminary and limited data.
  • Further systematic analysis is required to determine the safety and efficacy of various HSCT approaches in MS.
  • Publication bias may affect the perception of positive outcomes.